Economic Atlas
Companies/BeOne Medicines AG
Company profile

BeOne Medicines AG

NASDAQ: ONC · Healthcare · Biotechnology
PublicHQ Basel, PACIK 0001651308Reports USD
#58 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
75B+
Revenue TTM
$5.7B
Rev growth YoY (TTM)
+37.4%
Net income (FY)
$286.9M
Employees
12,000
as of 2026-08-04
Market cap
$33.5B
as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$5.3B$5.3B2025
Net income$286.9M$286.9M2025
Operating income$447.1M$447.1M2025
Total assets$8.2B$8.2B2025
Liabilities$3.8B$3.8B2025
Equity$4.4B$4.4B2025

Revenue trend

FY2020 – FY2025 · USD
FY20
FY20
FY20
FY22
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product99%
Collaboration1%
By geography
UNITED STATES56%
CHINA32%
Europe12%
The read

What is BeOne Medicines AG’s revenue?

BeOne Medicines AG booked $5.3B in FY2025 revenue, growing 40% year over year — faster than most Healthcare companies we track, at a 5.4% net margin.

Peers · Healthcare
Humana Inc.86AOption Care Health, Inc.83B+Select Medical Holdings Corporation74BPACS Group, Inc.53DResMed Inc.88AIncyte Corporation90A
Key facts
CEOJohn V. Oyler
SectorHealthcare
IndustryBiotechnology
HeadquartersBasel, PA
ExchangeNASDAQ: ONC
Employees12,000
IPO date2016-02-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.